has been cited by the following article(s):
[1]
|
Immunological profile of diabetic foot ulcers: update review
|
|
Razzaq, MH Hussein - Muthanna Medical Journal,
2023 |
|
|
[2]
|
Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY)
|
|
in vivo,
2022 |
|
|
[3]
|
Cytokine profiling for Egyptian diabetic patients with nephropathy
|
|
Journal of Medicine in …,
2022 |
|
|
[4]
|
The promising role of microbiome therapy on biomarkers of inflammation and oxidative stress in type 2 diabetes: a systematic and narrative review
|
|
Frontiers in …,
2022 |
|
|
[5]
|
Association of Interleukin-17A Genotypes with their Serum Levels in Iraqi Type 2 Diabetic Patients
|
|
Wasit Journal of Pure sciences,
2022 |
|
|
[6]
|
A holistic view of the goto-kakizaki rat immune system: decreased circulating immune markers in non-obese type 2 diabetes
|
|
Frontiers in …,
2022 |
|
|
[7]
|
Relations between Interlukin-6 and Some Biochemical Parameters in Diabetic Foot Syndrome
|
|
2021 |
|
|
[8]
|
Relations between Interleukin-6 and Some Biochemical Parameters in Diabetic Foot Syndrome.
|
|
Salih, ZM Ali - Medico-Legal Update,
2021 |
|
|
[9]
|
Alcohol Consumption as a Risk Factor for the Development of Type 2 Diabetes Mellitus in Patients at Hospital Central de Nampula, Northern Mozambique
|
|
2020 |
|
|
[10]
|
Evaluate microbial profile and IL-17 level in transmission transfusion infection patients
|
|
|
|
|
[11]
|
Evaluation of Serum IL-17A Levels in Diabetes with Chronic Periodontitis Patients.(2022)
|
|
|
|
|
[12]
|
УТИЦАЈ КВАЛИТЕТА МЕТАБОЛИЧКЕ КОНТРОЛЕ НА ИСХОД ЛЕЧЕЊА ФИЗИКАЛНИМ ПРОЦЕДУРАМА БОЛЕСНИКА СА ГОНАРТРОЗОМ И ДИЈАБЕТЕС …
|
|
|
|
|
[1]
|
Immunological profile of diabetic foot ulcers: update review
Muthanna medical journal,
2023
DOI:10.52113/1/1/2023-38-43
|
|
|
[2]
|
VDR downregulation and promoter hypermethylation as one of the causes for triggering type 2 diabetes mellitus: Clinical and molecular studies
Journal of Diabetes & Metabolic Disorders,
2023
DOI:10.1007/s40200-023-01266-6
|
|
|
[3]
|
VDR downregulation and promoter hypermethylation as one of the causes for triggering type 2 diabetes mellitus: Clinical and molecular studies
Journal of Diabetes & Metabolic Disorders,
2023
DOI:10.1007/s40200-023-01266-6
|
|
|
[4]
|
A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
Frontiers in Immunology,
2022
DOI:10.3389/fimmu.2022.896179
|
|
|
[5]
|
The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review
Frontiers in Nutrition,
2022
DOI:10.3389/fnut.2022.906243
|
|
|